Novartis (NOVN SW) is to add radioligand therapy manufacturing facility within Florida. Advancing USD 23bln investment projected announced in April 2025.

Novartis is expanding its operations with a new manufacturing facility in Florida, which is part of a significant $23 billion investment first announced in April 2025.

Newsquawk StaffPublished On the live feed at 2 more headlines followed before this page went public
Newsquawk headlinesUTC

Atlanta Fed GDPNow (Q4): 5.1% (prev. 5.4%), following metrics from the BLS and Census Bureau

Reliance is reportedly in talks with the US government for authorisation to import crude from Venezuela, according to sources

Novartis (NOVN SW) is to add radioligand therapy manufacturing facility within Florida. Advancing USD 23bln investment projected announced in April 2025.

US White House Economic Adviser Hassett says there is a detailed back-up plan for tariffs. The Fed needs to cut more. A lot of work done on getting reliable BLS figures.

Russia has, according to Ukraine, hit two vessels in ports in the region of Odesa

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This strategic move not only enhances its production capabilities in the growing radioligand therapy market but also highlights its commitment to expanding its footprint in the lucrative U.S. healthcare sector. Investors may view this expansion as a positive signal for Novartis’ long-term growth potential and might impact sentiment in related sectors such as pharmaceuticals and biotechnology.

Related headlines

The whole workspace, free to try.

Try it free